BALAXI

Balaxi Pharmaceuticals Share Price Balaxi Pharmaceuticals

₹495.95
7.05 (1.44%)
29 March, 2024 19:08 BSE: NSE: BALAXIISIN: INE618N01014

Start SIP in Balaxi Pharmaceuticals

Start SIP

Balaxi Pharmaceuticals Performance

Day Range

  • Low 483
  • High 519
₹ 495

52 Week Range

  • Low 400
  • High 686
₹ 495
  • Open Price509
  • Previous Close489
  • Volume10638

Balaxi Pharmaceuticals Share Price

  • Over 1 Month -19.69%
  • Over 3 Month 13.11%
  • Over 6 Month 9.46%
  • Over 1 Year -6.71%

Balaxi Pharmaceuticals Key Statistics

P/E Ratio -103.5
PEG Ratio 0.9
Market Cap Cr 541
Price to Book Ratio 3
EPS 15.1
Dividend 0
Relative Strength Index 44.26
Money Flow Index 52.23
MACD Signal -10.7
Average True Range 37.67
Balaxi Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 13172530
Operating Expenses Qtr Cr 12162125
Operating Profit Qtr Cr 0145
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0011
Net Profit Qtr Cr 0134
IndicatorMar 2023
Total Revenue Annual Cr 115
Operating Expenses Annual Cr 91
Operating Profit Annual in Cr 17
Depreciation Cr 1
Interest Annual Cr 0
Tax Annual Cr 6
Net Profit Annual Cr 16
IndicatorMar 2023
Cash from Operating Activity Annual Cr -7
Cash from Investing Activity Annual Cr -2
Cash from Financing Annual Activity Cr 26
Net Cash Flow Annual Cr 17
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 92
Fixed Assets Annual Cr 11
Total Non Current Assets Annual Cr 31
Total Current Assets Annual Cr 99
Total Assets Annual Cr 130
IndicatorMar 2023
Book Value Per Share Annual Rs 90
ROE Annual % 18
ROCE Annual % 24
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 61556681
Operating Expenses Qtr Cr 47445768
Operating Profit Qtr Cr 1411913
Depreciation Qtr Cr 0101
Interest Qtr Cr 0000
Tax Qtr Cr 1123
Net Profit Qtr Cr 1414-418
IndicatorMar 2023
Total Revenue Annual Cr 339
Operating Expenses Annual Cr 280
Operating Profit Annual in Cr 57
Depreciation Cr 2
Interest Annual Cr 1
Tax Annual Cr 11
Net Profit Annual Cr 46
IndicatorMar 2023
Cash from Operating Activity Annual Cr 6
Cash from Investing Activity Annual Cr -11
Cash from Financing Annual Activity Cr 26
Net Cash Flow Annual Cr 21
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 183
Fixed Assets Annual Cr 19
Total Non Current Assets Annual Cr 46
Total Current Assets Annual Cr 194
Total Assets Annual Cr 240
IndicatorMar 2023
Book Value Per Share Annual Rs 180
ROE Annual % 25
ROCE Annual % 31
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 18

Balaxi Pharmaceuticals Technicals

EMA & SMA

Current Price
₹495.95
7.05 (1.44%)
pointer
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • ₹515.67
  • 50 Day
  • ₹513.66
  • 100 Day
  • ₹495.41
  • 200 Day
  • ₹489.79
  • 20 Day
  • ₹521.28
  • 50 Day
  • ₹520.36
  • 100 Day
  • ₹473.52
  • 200 Day
  • ₹474.89

Balaxi Pharmaceuticals Resistance and Support

PIVOT
₹499.14
Resistance
First Resistance 515.52
Second Resistance 535.08
Third Resistance 551.47
RSI 44.26
MFI 52.23
MACD Single Line -10.70
MACD -14.47
Support
First Resistance 479.57
Second Resistance 463.18
Third Resistance 443.62

Balaxi Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 10,638 664,024 62.42
Week 8,619 509,311 59.09
1 Month 13,648 671,227 49.18
6 Month 11,404 582,856 51.11

Balaxi Pharmaceuticals Result Highlights

Balaxi Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Balaxi Pharmaceutica is involved in the business activities of Other specialized wholesale. Company’s Total Operating Revenue is Rs. 108.14 Cr. and Equity Capital is Rs. 10.18 Cr. for the Year ended 31/03/2023. Balaxi Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1942 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L25191TG1942PLC121598 and registration number is 000045.
Market Cap 540
Sales 85
Shares in Float 0.35
No of funds 3
Yield
Book Value 5.48
U/D Vol ratio 1.6
LTDebt / Equity
Alpha -0.06
Beta 0.49

Balaxi Pharmaceuticals

Owner NameFeb-24Dec-23Sep-23Jun-23
Promoters 67.8%71.22%71.22%71.22%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors 17.45%18.58%18.58%18.58%
Financial Institutions/ Banks 0.02%0.03%0.03%0.03%
Individual Investors 6.51%6.63%6.62%6.57%
Others 8.22%3.54%3.55%3.6%

Balaxi Pharmaceuticals Management

Name Designation
Mr. Ashish Maheshwari Managing Director
Mrs. Minoshi Maheshwari Non Executive Director
Mrs. Purnima Singh Kamble Independent Director
Mr. M Srinivas Rao Independent Director
Mr. Gandhi Gamji Independent Director
Mr. Kunal M Bhakta Independent Director

Balaxi Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Balaxi Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-02 Quarterly Results
2023-08-03 Quarterly Results
2023-05-29 Audited Results & Dividend
2023-02-01 Quarterly Results
2022-11-05 Quarterly Results

Balaxi Pharmaceuticals MF Shareholding

Name Amount(cr)

Balaxi Pharmaceuticals FAQs

What is Share Price of Balaxi Pharmaceuticals ?

Balaxi Pharmaceuticals share price is ₹495 As on 29 March, 2024 | 18:54

What is the Market Cap of Balaxi Pharmaceuticals ?

The Market Cap of Balaxi Pharmaceuticals is ₹540.5 Cr As on 29 March, 2024 | 18:54

What is the P/E ratio of Balaxi Pharmaceuticals ?

The P/E ratio of Balaxi Pharmaceuticals is -103.5 As on 29 March, 2024 | 18:54

What is the PB ratio of Balaxi Pharmaceuticals ?

The PB ratio of Balaxi Pharmaceuticals is 3 As on 29 March, 2024 | 18:54

Q2FY23